102 The Global HIV Epidemics among People Who Inject Drugs
IOM (2007). Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence. Washington, D.C.: Institute of Medicine of The National Academies Press (IOM), Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk Countries. Judice, N. (2012). Use of Naltrexone and its Formulations in the Treatment of Opioid Dependence in the Russian Federation: Situation Analysis. Washington, DC: Futures Group, Health Policy Project. Jurgens, R. and G. Betteridge (2005). “Prisoners who inject drugs: public health and human rights imperatives.” Health and Human Rights 8 (2): 46–74. Jurgens, R. and J. Csete (2012). “In the name of treatment: ending abuses in compulsory drug detention centers.” Addiction 107 (4): 689–691. Jürgens, R., J. Csete, et al. (2010). “People who use drugs, HIV, and human rights.” The Lancet. Jurgens, R., M. Nowak, et al. (2011). “HIV and incarceration: prisons and detention.” Journal of the International AIDS Society 14: 26. Käll, K., U. Hermansson, et al. (2007). “The effectiveness of needle exchange programmes for HIV prevention—a critical review.” The Journal of Global Drug Policy and Practice 1 (3). Kawewa, J. (2005). Situational Analysis on HIV/AIDS in Kenya. UNESCO. Nairobi: University of Nairobi. Kawichai, S., D. D. Celentano, et al. (2006). “HIV Voluntary Counseling and Testing and HIV Incidence in Male Injecting Drug Users in Northern Thailand: Evidence of an Urgent Need for HIV Prevention.” JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (2): 186–193 110.1097/1001.qai.0000179431.0000142284.0000179433e. Kenya IDU TWG (2011). Kenya IDU TWG Breakfast Meeting, Nairobi (November 11, 2011). Kerrigan, D., A. L. Wirtz, et al. (2012). The Global Epidemics of HIV among Sex Workers. T. Washington, DC: World Bank. Khan, A. and A. Khan (2011). “Performance and coverage of HIV interventions for injection drug users: Insights from triangulation of programme, field and surveillance data from Pakistan.” The International Journal on Drug Policy. Khan, A. A. and A. Khan (2010). “The HIV Epidemic in Pakistan.” J Pak Medical Association 60 (4): 300–307. Kidorf, M. and V. L. King (2008). “Expanding the public health benefits of syringe exchange programs.” Canadian Journal of Psychiatry / Revue canadienne de psychiatrie 53 (8): 487–495. Kimani, J., R. Kaul, et al. (2008). “Reduced rates of HIV acquisition during unprotected sex by Kenyan female sex workers predating population declines in HIV prevalence.” AIDS 22 (1): 131–137. Kwon, J. A., J. Iversen, et al. (2009). “The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis.” JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (4): 462. Lawrinson, P., R. Ali, et al. (2008). “Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.” Addiction 103 (9): 1484–1492. Lei, Z., Y. Lorraine, et al. (2011). “Needle and syringe programs in Yunnan, China yield health and financial return.” BMC Public Health 11. MacArthur, G. J., Minozzi, S, Martin, N., Vickerman, P., Deren, S., and J. Bruneau, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012;345:e5945